32-kDa protein derived from Mycobacterium tuberculosis and related peptides

US7083797B2 · kind B2 · utility

Assignee

• N.V. Innogenetics S.A. · BE

Inventors

• Jean Content · Sint-Genesius-Rode, BE
• Lucas De Wit · Puurs, BE
• Jacqueline De Bruyn · Sint-Genesius-Rode, BE
• Jean-Paul Van Vooren · Sint-Pieters-Leeuw, BE

Key dates

• Filing date: Dec 23, 2002
• Grant date: Aug 1, 2006
• Expiry date: Dec 23, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K14/35
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention relates to recombinant polypeptides and peptides and particularly to the polypeptide containing in its polypeptidic chain the following amino acid sequence: the one extending from the extremity constituted by nucleotide at position (1) to the extremity constituted by nucleotide at position (194) represented in FIG. 4a and FIG. 4b. The polypeptides and peptides of the invention can be used for the diagnostic of tuberculosis, and can also be part of the active principle in the preparation of vaccine against tuberculosis.